Klara M. Kirschbaum
Frankfurt Am Main, HE 60590, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
DNMT3A-driven clonal haematopoiesis induces semaphorin 4A-dependent endothelial activation in heart failure.
Journal: Cardiovascular research
Published: April 22, 2026
Prognostic significance of somatic mutations in myeloid cells of men with chronic heart failure - interaction between loss of Y chromosome and clonal haematopoiesis.
Journal: European journal of heart failure
Published: April 08, 2025
Fulminant myocarditis: outcome predictors in an international cohort study.
Journal: European heart journal
Published: January 25, 2025
DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts.
Journal: Nature communications
Published: December 23, 2022
SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure-further evidence for improved hemodynamics by continuous pressure monitoring.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: May 12, 2021
Multiple Somatic Mutations for Clonal Hematopoiesis Are Associated With Increased Mortality in Patients With Chronic Heart Failure.
Journal: Circulation. Genomic and precision medicine
Published: June 30, 2020
Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations.
Journal: European heart journal
Published: April 23, 2020
In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 02, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026